Information about http://officeofbudget.od.nih.gov/ui/2008/Summary%20of%20FY%202009%20Budget-Press%20Release.pdf
National Institutes of Health Summary of the FY 2009 President's…
Tags: aids, aids program, appropriation, budget at a glance, diabetes, diabetes initiative, discretionary budget authority, health dollars, health summary, institutes of health, labor hhs, national institutes of health, nih, nih budget, nih program, success rate, type i diabetes,Pages: 9
Language: english
Created: Mon Feb 4 10:30:08 2008
Display cached document
Page 1
Page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
National Institutes of Health
Summary of the FY 2009 President's Budget
February 4, 2008
National Institutes of Health FY 2009 President's Budget 2
NIH Budget at a Glance
National Institutes of Health
( dollars in millions)
Change from
FY 2007 FY 2008 FY 2009 FY 2008
Actual Enacted Estimate Enacted
Labor/HHS Discretionary
Budget Authority (B.A.) $28,899 $29,230 $29,230 $0
Interior B.A. $79 $78 $78 $0
Total Discretionary B.A. $28,978 $29,307 $29,307 $0
Type I Diabetes Initiative $150 $150 $150 $0
Total B. A. $29,128 $29,457 $29,457 $0
NIH Program Level $29,137 $29,465 $29,465 $0
AIDS Program $2,906 $2,913 $2,913 $0
Number of Competing RPGs 10,323 9,771 9,757 -14
Total Number of RPGs 38,845 38,239 38,257 18
Success Rate 21% 19% 18% -1%
FTEs 16,997 17,138 17,254 +116
The FY 2009 Discretionary Budget Authority request for the NIH is $29,230 million, equal to
the FY 2008 appropriation. The total NIH budget authority with the Type I Diabetes Initiative
for FY 2009 is $29,380 million. It provides a total Program Level in FY 2009 of $29,465
million, the same as the FY 2008 Enacted Level.
The FY 2009 Request maintains the AIDS research program at the FY 2008 level of $2,913
million. In addition, NIH will provide $300 million to the Global Fund for HIV/AIDS,
Tuberculosis and Malaria.
NIH has modified its traditional budget display by mechanism so that activities of the National
Cancer Institute's Cancer Prevention and Control Program and the National Library of Medicine
are allocated among the various trans-NIH mechanisms of support.
Moving Towards Medicine in 2030
Fifty years ago, a man died instantly from a heart attack. Twenty five years ago, his son
experienced chest pains and received a bypass operation. This year, his grandson was diagnosed
with high cholesterol and is on statins. What does the future hold for his great-grandson? Over
the years, through discoveries from basic research, population studies, and clinical research, we
have moved from--doing nothing about heart disease, to relying largely on invasive surgeries,
such as coronary bypass, to prevention through the use of blood pressure and cholesterol-
National Institutes of Health FY 2009 President's Budget 3
lowering drugs. We have cut the deaths from heart disease by 50% over the last 30 years, but
can we take the next step to predict or preempt the development of heart disease? Can we
improve treatment so that it is most effective and personalized?
In the past 40 years, NIH funded research has successfully reduced the mortality and morbidity
of once acute and lethal conditions by finding ways to improve treatment -- even in late stages.
These advances have helped change the landscape of disease from acute to chronic diseases,
which now form the largest component of health burden. Biomedical research is the key to
transform medicine from the curative health care paradigm of the past where we intervened late
in the natural history of a disease, to a preemptive model in which the onset of disease is
significantly delayed or even never allowed to develop.
Based on the progress and discoveries made through NIH-supported research just in the last few
years, NIH can foresee its vision of a future and transformative era of medicine and health care
that is increasingly predictive, personalized and preemptive. This era will include more active
participation by individuals and communities in their own care. Support for NIH will increase
our ability to explore and understand the fundamental causes of disease at the earliest molecular
stages and allow us to expand the ability to predict a disease before it develops. As we expand
the knowledge of individual genetic differences and response to environment we will increase
our ability to implement individually targeted or personalized treatment. Ultimately, this
research should allow us to preempt disease before it occurs. Finally, critical components of this
new revolutionary approach to 21st century medicine will result in greater participation of
individuals, communities and healthcare institutions
Our vision for this future is emerging from NIH-funded researchers across the nation, as well as
the thousands of scientists and laypersons from whom the NIH solicits input through our study
sections and advisory councils. History demonstrates no one can predict where the next great
discovery or life-saving breakthrough will occur. Therefore, NIH employs a robust system to
inspire bright minds to propose their best and most innovative ideas to tackle current and
emerging public health problems. The proposals undergo a rigorous peer review process and
only those with most promise receive support. On occasion, NIH management takes a more
active role to stimulate research in a pressing area like bioterrorism countermeasures or
pandemic influenza. However, the workhorse of NIH research is the investigator-initiated
project. These projects consistently provide discoveries that make Americans healthier and
provide a training ground for the highly skilled individuals who work in the nation's
pharmaceutical, biotechnology, and academic career fields. The Nation's return on investment
in NIH is demonstrated by improved health for the Nation and this investment has strengthened
the Nation's competitiveness and its economy.
US health expenditures continue to grow far faster than general inflation. Investments in NIH
have lead to progress in the fight against heart disease, cancer, and AIDS, among many others,
and have helped save lives and avoid unnecessary health expenditures. At NIH, we believe
health care costs will not be tempered unless we accelerate the discovery of transformative ways
of practicing medicine which can only happen through research.
National Institutes of Health FY 2009 President's Budget 4
In the FY 2009 budget request, we have identified the following strategic priorities:
Support New Investigators We will continue to nurture a vibrant, creative research
workforce, and include sufficient numbers of new investigators with new ideas and new skills in
areas such as interdisciplinary research. In FY 2007, we set a goal to sustain 1500 new
investigators each year-- based on the NIH five year historical average. We exceeded this goal.
To help ensure the pipeline of future investigators is maintained as the current workforce ages
and begins to retire, we plan to continue support for the Pathway to Independence program with
another 170 awards. In FY 2009, the Pathway program will support approximately 500
awardees at a total of $71 million. In FY 2009 we will also support approximately 25 New
Innovator Awards, for a total of $56 million in the NIH Common Fund.
NIH Director's Bridge Award -- The FY 2009 Request level includes $91.2 million to continue
the NIH Director's Bridge Award program, to protect our investment in well-established and
meritorious investigators with little or no other significant support.
NIH Common Fund We plan continued support for the Common Fund in FY 2009 with a
program level of $534 million, an increase of $38 million over the FY 2008 Enacted Level. The
Common Fund is an incubator for new ideas and initiatives that will accelerate the pace of
discovery. These initiatives are focused on efforts that no single or small group of Institutes or
Centers could conduct on their own, and have potential to transform biomedical and behavioral
research.
The second cohort of initiatives in the Common Fund was launched in FY 2007, and continues
into FY 2008 and FY 2009. The two new program areas that began preparatory studies and
projects in FY 2007 include projects in the 1) Human Microbiome--a project to characterize the
microbial content of sites in the human body and their relationship to disease and the
environment; and 2) Epigenomics--the study of stable genetic modifications and their
relationship to disease. Funds are identified in the FY 2009 Common Fund for the continuation
of these projects. In addition, the FY 2009 request has reserved up to $46 million for new
projects that will be developed during FY 2008. NIH will also continue the New Innovator
Awards, at a level of $56 million.
National Institutes of Health FY 2009 President's Budget 5
FY 2009 President's Budget Request
Total NIH Budget Authority
$29,457 Million
Research Centers
Research Project Grants 10.1%
52.7%
Other Research
6.1%
Research Training
2.7%
R&D Contracts
11.1%
Intramural Research
10.6%
Res. Mgmt. & Support
4.6%
All Other
2.2%
Mechanism Discussion
Research project grants (RPGs) are the primary mechanism for funding of investigator-initiated
biomedical research; therefore, support for RPGs remains a high priority in the FY 2009
President's Budget. This will enable NIH to maintain support for ongoing research and to
support new researchers and new ideas to maintain the vitality of biomedical research.
Inflationary pressure on our research portfolio and scientific purchasing power remains a key
concern; however, we have made the difficult decision to again eliminate inflationary increases
for RPGs. While no inflationary increases are provided for direct, recurring costs in non-
competing RPG's in the FY 2009 President's Budget, where the NIH has committed to a
programmatic increase in an award, such increases will be provided. The average cost of
competing RPGs will remain at the FY 2008 level.
In the FY 2009 President's Budget, NIH proposes to increase support for research centers to
$2,963 million, a 0.7% increase above the FY 2008 Enacted Level. This request level will
continue to provide program growth for the Clinical and Translational Science Awards (CTSAs).
Support for Other Research decreases by $23 million, or 1.3%. NIH will fund a third cohort of
researchers in the Pathway to Independence program, with around 170 awards for $15 million.
Also in FY 2009, the 1st cohort of Pathway awards "graduate" into noncompeting RPGs. Total
support for the Pathway program in FY 2009 is $71 million and over 500 recipients. The
National Institutes of Health FY 2009 President's Budget 6
Roadmap program, Nanomedicine Centers, will continue to use the Flexible Research Authority
of $25 million, the same amount as FY 2008.
In order to achieve the NIH's research objectives, it is essential to ensure that highly trained
scientists will be available to address the nation's biomedical, behavioral and clinical research
needs. Pre-doctoral fellows, who currently receive $20,772, have not seen a stipend increase
since FY 2004. Post-doctoral fellows, who begin at $36,996, have not seen a stipend increase
since FY 2006 (for 0 to 1 year of experience only). In the FY 2009 President's Budget, NIH
proposes modest stipend increases of 1% for both pre- and post-doctoral fellows. At the FY 2009
President's Budget level, NIH will support 17,586 Full-Time Training Positions (FTTPs), an
increase of 17 FTTPs over the FY 2008 level. It is important to ensure the pipeline of future
investigators is adequate as the current workforce ages and begins to retire. NRSA funding
increases by $5 million or 0.6% over the FY 2008 Enacted Level.
R&D contracts increase by $33 million and 1% compared to the FY 2008 Enacted Level. This
increase includes $5 million in additional funds for the Global Fund for HIV/AIDS, Tuberculosis
and Malaria to other high-priority NIH research programs. Total support for the Global Fund in
FY 2009 is $300 million.
In the FY 2009 Submission, support for the NIH intramural research program would increase by
1.6% above the FY 2008 Enacted Level, for a total of $3,119 million. This increase maintains the
intramural program at approximately 11% of NIH's overall budget.
For FY 2009, RMS would be funded at $1,361 million, an increase of $20 million and 1.5%
above the FY 2008 Enacted Level, enabling appropriate administration of NIH resources. This
will provide NIH with sufficient capacity to manage its research portfolios, and to ensure
appropriate stewardship of all funds.
National Institutes of Health FY 2009 President's Budget 7
FY 2009 NIH Request
Percent Change From Selected FY 2008 Enacted
Budget Mechanisms
-
7.5%
5.5%
3.5%
1.0% 1.6% 1.5%
0.7% 0.6%
1.5% -0.1% -1.3%
-0.5%
Research Research Other Research R&D Intramural Res. Mgmt.
Project Centers Research Training Contracts Research & Support
Grants
The OD decreases by $52 million and 5%. The FY 2009 Request includes $91.2 million for the
NIH Director's Bridge Award program. No funds are provided for the National Children's
Health Study.
The FY 2009 Request Level for B&F is $133.4 million. Of this amount, $7.8 million would be
provided to the National Cancer Institute (NCI) for repairs and improvements at the NCI-
Frederick campus. The B&F appropriation request of $125.6 million provides for essential-only
Repairs and Improvements, a modest amount for concept development studies and essential
safety and regulatory compliance.
National Institutes of Health FY 2009 President's Budget 8
NATIONAL INSTITUTES OF HEALTH
Summary of Appropriations
(Dollars in millions)
FY 2007 Budget FY 2008 FY 2009
Appropriation Authority 1/ 2/ Enacted 1/ 2/ Estimate 2/ 2009/2008
Includes AIDS Includes AIDS Includes AIDS $ Change
NCI 4,795 4,805 4,810 5
NHLBI 2,919 2,922 2,925 3
NIDCR 390 390 391 0
NIDDK 2/ 1,856 1,857 1,858 2
NINDS 1,535 1,544 1,545 1
NIAID 3/ 4,366 4,561 4,569 8
NIGMS 1,936 1,936 1,938 2
NICHD 1,254 1,255 1,256 1
NEI 667 667 668 1
NIEHS 642 642 643 1
NIA 1,047 1,047 1,048 1
NIAMS 508 509 509 0
NIDCD 394 394 395 1
NIMH 1,404 1,405 1,407 1
NIDA 1,000 1,001 1,002 1
NIAAA 436 436 437 0
NINR 137 137 138 0
NHGRI 486 487 488 1
NIBIB 298 299 300 2
NCRR 1,144 1,149 1,160 11
NCCAM 121 122 122 0
NCMHD 199 200 200 0
FIC 66 67 67 0
NLM 320 321 323 3
OD 1,047 1,109 1,057 -52
B&F 81 119 126 7
Type 1 Diabetes -150 -150 -150 0
Subtotal, Labor/HHS 28,899 29,230 29,230 0
Interior Approp. for Superfund Res. 79 78 78 0
Total, NIH Discretionary B.A. 28,978 29,307 29,307 0
Type 1 Diabetes 150 150 150 0
Total, NIH Budget Authority 29,128 29,457 29,457 0
NLM Program Evaluation
ONDCP - 8 - 8 - 8 0
Total, Prog. Level 29,137 29,465 29,465 0
Totals may not add due to rounding
1/ Includes comparable program transfers
2/ Includes funds for the Type 1 Diabetes Initiative.
3/ Includes funds to be transferred to the Global Fund for HIV/AIDS, Malaria, and Tuberculosis.
National Institutes of Health FY 2009 President's Budget 9
NATIONAL INSTITUTES OF HEALTH
Budget Mechanism - Total
(Dollars in millions)
FY 2007 FY 2008 FY 2009
MECHANISM Actual 1/ Enacted Estimate Change
Research Grants: No. Amount No. Amount No. Amount No. Amount
Research Projects:
Noncompeting 26,741 $11,005 26,728 $11,194 26,759 $11,169 31 -$25
Administrative supplements (1,633) 205 (1,684) 195 (1,776) 214 (92) 19
Competing 10,323 3,788 9,771 3,534 9,757 3,520 (14) -14
Subtotal, RPGs 37,064 14,998 36,499 14,923 36,516 14,903 17 -20
SBIR/STTR 1,781 629 1,740 620 1,741 620 1 0
Subtotal, RPGs 38,845 15,627 38,239 15,543 38,257 15,523 18 -20
Research Centers:
Specialized/comprehensive 1,193 2,238 1,150 2,225 1,155 2,231 5 6
Clinical research 88 381 88 418 72 423 -16 5
Biotechnology 109 137 106 124 102 124 -4 0
Comparative medicine 54 124 54 122 60 131 6 9
Research Centers in Minority Institutions 28 54 28 54 28 54 0 0
Subtotal, Centers 1,472 2,934 1,426 2,943 1,417 2,963 -9 20
Other Research:
Research careers 4,293 663 4,451 688 4,449 685 -2 -3
Cancer education 89 31 89 32 89 32 0 0
Cooperative clinical research 435 425 427 425 427 425 0 0
Biomedical research support 188 98 143 64 144 64 1 0
Minority biomedical research support 165 111 161 110 161 110 0 0
Other 1,756 465 1,726 490 1,706 470 -20 -20
Subtotal, Other Research 6,926 1,793 6,997 1,809 6,976 1,786 -21 -23
Total Research Grants 47,243 20,354 46,662 20,295 46,650 20,272 -12 -23
Ruth L. Kirschstein Training Awards: FTTPs FTTPs FTTPs
Individual awards 2,982 121 2,997 122 3,004 124 7 2
Institutional awards 14,614 661 14,572 660 14,582 663 10 3
Total, Training 17,596 782 17,569 782 17,586 787 17 5
Research & development contracts 2,895 2,985 2,886 3,242 2,913 3,275 27 33
(SBIR/STTR) (98) (26) (106) (29) (106) (29) (0) (0)
Intramural research 3,035 3,069 3,119 50
Research management and support 1,317 1,341 1,361 20
Extramural Construction 14 0 0 0
0
Office of the Director 473 524 432 -92
(Appropriation) (1,047) (1,109) (1,057) (-52)
Buildings and Facilities 1/ 89 127 133 6
(Appropriation) (81) (119) (126) (7)
NIH Roadmap for Medical Research* (483) (496) (534) (38)
Type 1 Diabetes 2/ -150 -150 -150 0
Subtotal, Labor/HHS Budget Authority 28,899 29,230 29,230 0
Interior Appropriation for Superfund Res. 79 78 78 0
Total, NIH Discretionary B.A. 28,978 29,307 29,307 0
Type 1 Diabetes 2/ 150 150 150 0
Total, NIH Budget Authority 29,128 29,457 29,457 0
NLM Program Evaluation 8 8 8 0
Total, Program Level 29,137 29,465 29,465 0
May not add due to rounding
*Included in above mechanisms.
1/ Includes the B&F appropriation plus the following included in NCI -- FY 06: $7.9M; FY 07: $7.9M; FY 08: $7.8M.
2/ Included in NIDDK -- FY 07: $150M; FY 08: $150M; FY 00: $150M for Type I Diabetes Initiative.
Numbers of grants identified in FY 2008 and FY 2009 are estimates, and WILL change as applications are
received and selected for funding.
NIH has modified its traditional budget display by mechanism so that activities of the National Cancer Institute's Cancer Prevention and Control Program and
the National Library of Medicine are allocated among the various trans-NIH mechanisms of support.